Responsible for providing scientific and strategic oversight for Immunology and/or Immuno-oncology development candidates through close collaboration with Program Coordinators and Compound Leaders (program team representatives) from various functional areas within NDS, Preclinical Development and ensuring strong partnership across other areas such as (biology, chemistry, regulatory, clinical, CMC, etc). [Senior Principal Scientist - Toxicology - eq. to Senior Director]

* Provide technical expertise in product safety and chemical risk assessment areas;* Oversee in vitro toxicology and human clinical studies;* Monitor and address ingredient safety and regulatory issues;* Manage, train, and coach junior toxicologists;* Represent Revlon on trade organization scientific committees.

Provide product safety and occupational toxicology support to clients by performing human risk assessment.Determine exposure limits for active pharmaceutical ingredients including biologics and small molecules.Establish acceptable (permissible) daily exposures for extractables and leachables, degradates, and other process impurities. Act as group leader for computational toxicology analyses (QSAR).

Provide expert knowledge and scientific support on inherent safety of the materials to US core clients. Conduct environmental and human health risk assessment.Critically review assessment methodologies, emerging science and regulatory guidelines and their implications.Work with material scientists to identify and promote the best technologies.Liaise with clients, regulators and external experts to further the safety programs.

Non-for-profit. SOT is committed to creating a safer and healthier world by advancing the science of toxicology. The Society promotes the acquisition and utilization of knowledge in toxicology, aids in the protection of public health, and facilitates disciplines. The Society has a strong commitment to education in toxicology and to the recruitment of students and new members into the profession.As a member of the executive board of the postdoctoral assembly, I contribute to the development of postdoctoral members by enhancing communication with the society leadership and by developing career and networking opportunities both online and at the annual meeting.

• Study of pregnancy-induced variations in Phase I metabolism in mice with emphasis on pesticide metabolism• Characterization of pyrethroid metabolism by human carboxylesterases variants• Development of an analytical approach to assess DNA methylation• Evaluation of the effect of lead on the function of the hypothalamic-pituitary-adrenal axis in occupationally exposed human subjects

• Characterization of human exposure to pyrethrins and pyrethroids among urban and rural population samples from the Province of Québec (CANADA) • Measurement of urinary excretion of CDCA, a pyrethroid metabolite, for the first time in North America• Comparative analysis of approaches to urine biomonitoring of pesticides